Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...
The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...
Public records clearly shows that for the past 25 years, CERN has repeatedly built inadequate FPGA-based Level-1 Triggers, necessitating multiple rebuilds. During the Higgs boson discovery ...
Discusses Market Trends, Demand Outlook and Strategic Updates Ahead of Quarterly Results December 18, 2025 12:00 PM ...
Background Predicting progression to aortic valve replacement (AVR) in moderate aortic stenosis (AS) is challenging. This ...
Future linear core TV advertising revenues will continue to decline by 6% to 8% for the next two years, according to MoffettNathanson Research. For 2025, total linear core TV ad revenues are expected ...
SMX's valuation story has quietly crossed a critical threshold. The company is no longer asking the market to underwrite a ...
Discover the top 3 undervalued Health Care Equipment & Supplies stocks for Thursday, December 11 based on AAII’s Stock Grades.
The future and certainty of SkyTrain expansion is at a crossroads, after 40 years of proven success and high ridership.
Grade entry begins 8 a.m. October 13 and ends at 5 p.m. October 23. Faculty not meeting the submission deadline for their reporting window will be required to submit via the Grade change workflow ...
HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, today announced that new clinical data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback